The UK’s AstraZeneca, which is working on an oral GLP-1, also views the drugs as part of a combination strategy. In other ...

Obesity is a chronic complex relapsing disease defined by abnormal and/or excessive fat accumulation that presents a risk to ...

Obesity can lead to severe health problems, like heart disease and diabetes. A new CDC report shows the number of kids and teens with obesity has risen sharply over the past two decades.

People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's ...

Adopting healthy habits such as staying hydrated, limiting salt intake, staying active, avoiding smoking and alcohol, being ...

Quebec's health insurance board currently doesn't cover Ozempic and similar weight-loss medication unless they are prescribed for patients who are diagnosed with diabetes.

Components of metabolic syndrome were associated with increased risks for all-cause and vascular dementia in a linear manner.

The active ingredient found in popular medications for Type 2 diabetes and weight loss, including Ozempic and Wegovy, may ...

Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known ...

Almost a third (32%) of people with underlying health conditions such as respiratory disease, diabetes and morbid obesity ...

Semaglutide medications — such as Ozempic, the popular diabetes medication — have been linked to a reduced risk of ...